Back

Novo Nordisk explores direct U.S. share listing on NYSE

Verifying
  • Novo Nordisk is exploring a direct share listing on the New York Stock Exchange.
  • The proposed change would move its U.S. listing away from American depositary receipts.
  • Novo Nordisk is described as one of the world's most valuable pharmaceutical companies.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.